The Patent Finder
DT

Definium Therapeutics US, Inc.

First filing 2020
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Previously recorded as Mind Medicine, Inc. (to 2026)

Nine patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Jan 2041. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jan 2041
Next term end
7
Patent families

When these terms end

Each bar runs from grant to computed term end. 2022 to 2043.
US 11,596,638 18-MC for Treatment of Substance Use Disorders Jan 8, 2041
US 11,532,396 System and Method for Patient Monitoring of Gastrointestinal Function Using Automated Stool Classifications Mar 26, 2041
US 12,097,184 Formulations of Psilocin That Have Enhanced Stability no later than Mar 4, 2042
US 12,611,399 Movement Disorders May 1, 2042
US 12,527,786 IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS no later than Aug 17, 2042
US 12,521,385 LYOPHILIZED ORALLY DISINTEGRATING TABLET FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS no later than Aug 17, 2042
US 12,036,220 LYOPHILIZED ORALLY DISINTEGRATING TABLET FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS Aug 17, 2042
US 11,896,670 Synthesis Routes to Access Mdma Prodrugs by Using Controlled and Non-Controlled Intermediates Aug 23, 2042
US 12,534,460 LSD Salt Crystal Forms Apr 24, 2043
202620302034203820422043
A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.
17 pending applications: term is not computable until grant.Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Aug 13, 2027
    The maintenance fee for Synthesis Routes to Access Mdma Prodrugs by Using Controlled and Non-Controlled Intermediates (US 11,896,670) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The largest of its 7 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 9 of 9

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 11,596,63818-MC for Treatment of Substance Use Disorders
In force
 · High confidence
In forceHigh confidence
US 11,532,396System and Method for Patient Monitoring of Gastrointestinal Function Using Automated Stool Classifications
In force
 · High confidence
In forceHigh confidence
US 12,097,184Formulations of Psilocin That Have Enhanced Stability
In force
 · Medium confidence
In forceMedium confidence
US 12,611,399Movement Disorders
In force
 · High confidence
In forceHigh confidence
US 12,036,220LYOPHILIZED ORALLY DISINTEGRATING TABLET FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS
In force
 · High confidence
In forceHigh confidence
US 12,521,385LYOPHILIZED ORALLY DISINTEGRATING TABLET FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS
In force
 · Medium confidence
In forceMedium confidence
US 12,527,786IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS
In force
 · Medium confidence
In forceMedium confidence
US 11,896,670Synthesis Routes to Access Mdma Prodrugs by Using Controlled and Non-Controlled Intermediates
In force
 · High confidence
In forceHigh confidence
US 12,534,460LSD Salt Crystal Forms
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 9: 17 applications pending · 24 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited